Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Marinus Pharmaceuticals Inc (MRNS)  
$0.55 0.00 (0.00%) as of 4:30 Mon 2/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 55,671,000
Market Cap: 30.62(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.23 - $1.9
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Marinus Pharmaceuticals is a pharmaceutical company focused on developing and commercializing products for patients suffering from rare genetic epilepsies and other seizure disorders. The U.S Food and Drug Administration approved the use of ZTALMY® (ganaxolone) oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder in patients two years of age and older. Ganaxolone is being developed in formulations for various routes of administration: intravenous and oral. Ganaxolone acts at both synaptic and extrasynaptic gamma-aminobutyric acid type A receptors, a target known for its anti-seizure, antidepressant and anxiolytic potential.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 5,933 5,933
Total Buy Value $0 $0 $6,526 $6,526
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 3,210 32,281 70,809
Total Sell Value $0 $1,733 $34,622 $409,584
Total People Sold 0 2 7 7
Total Sell Transactions 0 2 7 22
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 155
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Fischer Seth H.z. Director   –       •      –    2025-02-11 4 D $0.55 $1,265 D/D (2,300) 0     -
   Shafer Christina CHIEF COMMERCIAL OFFICER   •       –      –    2025-02-11 4 D $0.55 $26,745 D/D (48,628) 0     -
   Braunstein Scott CHAIRMAN AND CEO   •       •      –    2025-02-11 4 D $0.55 $98,745 D/D (179,536) 0     -
   Johnson Marvin Director   –       •      –    2025-02-11 4 D $0.55 $3,906 D/D (7,101) 0     -
   Pfanstiel Steven CFO AND COO   •       –      –    2025-02-11 4 D $0.55 $34,359 D/D (62,470) 0     -
   Ezickson Elan Director   –       •      –    2025-02-11 4 D $0.55 $1,265 D/D (2,300) 0     -
   Silverstein Christine Berni Director   –       •      –    2025-02-11 4 D $0.55 $2,586 D/D (4,702) 0     -
   Manning Martha E SVP, GEN. COUNSEL & CORP. SEC.   •       –      –    2025-02-11 4 D $0.55 $26,442 D/D (48,077) 0     -
   Mayleben Timothy M Director   –       •      –    2025-02-11 4 D $0.55 $1,265 D/D (2,300) 0     -
   Hulihan Joseph CHIEF MEDICAL OFFICER   •       –      –    2025-02-11 4 D $0.55 $30,564 D/D (55,570) 0     -
   Fischer Seth H.z. Director   –       •      –    2025-02-07 4 D $0.55 $6,989 D/D (12,707) 2,300     -
   Shafer Christina CHIEF COMMERCIAL OFFICER   •       –      –    2025-02-07 4 D $0.55 $10,328 D/D (18,778) 48,628     -
   Braunstein Scott CHAIRMAN AND CEO   •       •      –    2025-02-07 4 D $0.55 $68,785 D/D (125,064) 179,536     -
   Johnson Marvin Director   –       •      –    2025-02-07 4 D $0.55 $2,964 D/D (5,389) 7,101     -
   Pfanstiel Steven CFO AND COO   •       –      –    2025-02-07 4 D $0.55 $9,517 D/D (17,303) 62,470     -
   Ezickson Elan Director   –       •      –    2025-02-07 4 D $0.55 $4,730 D/D (8,600) 2,300     -
   Silverstein Christine Berni Director   –       •      –    2025-02-07 4 D $0.55 $5,169 D/D (9,398) 4,702     -
   Manning Martha E SVP, GEN. COUNSEL & CORP. SEC.   •       –      –    2025-02-07 4 D $0.55 $6,702 D/D (12,186) 48,077     -
   Mayleben Timothy M Director   –       •      –    2025-02-07 4 D $0.55 $7,676 I/I (13,957) 0     -
   Mayleben Timothy M Director   –       •      –    2025-02-07 4 D $0.55 $2,530 D/D (4,600) 2,300     -
   Hulihan Joseph CHIEF MEDICAL OFFICER   •       –      –    2025-02-07 4 D $0.55 $9,435 D/D (17,155) 55,570     -
   Johnson Marvin   –       •      –    2025-01-21 4 AS $0.54 $869 D/D (1,610) 12,490 1%     
   Ezickson Elan   –       •      –    2025-01-21 4 AS $0.54 $864 D/D (1,600) 10,900 1%     
   Mayleben Timothy M   –       •      –    2024-10-10 4 GD $0.00 $0 I/I 8,300 10,637     -
   Braunstein Scott CHAIRMAN AND CEO   •       •      –    2024-08-14 4 AB $1.10 $6,526 D/D 5,933 304,600 -79%     
  155 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us